Loading data, please wait a moment. We are fetching the latest content from the server and validating, organizing, and rendering it to ensure the information you see is accurate, complete, and up to date. Loading speed may be affected by your network, device performance, or the current amount of data, so a brief wait is normal. To avoid extra delays caused by duplicate requests, please don't refresh frequently or repeatedly click buttons, and don't close the page or switch to an offline network. The page will update automatically once the data is ready. If it takes noticeably longer, check your network connection and try refreshing or coming back later. If the issue persists, please let us know so we can investigate. Thanks for your patience and understanding.
Jane He es socia general de YZi Labs y anteriormente fue analista en Barclays y directora operativa (COO) de Apeiron Capital. Desde que se graduó en la Stanford Graduate School of Business (Stanford GSB), Jane cuenta con un sólido historial en biotecnología y tecnología médica, persiguiendo activamente oportunidades disruptivas en la intersección entre la inteligencia artificial (AI) y la biotecnología. Su experiencia abarca terapias contra el cáncer, edición génica, tratamientos metabólicos y soluciones de biotecnología impulsadas por IA, aportando un enfoque visionario a la inversión.